The effect of COVID-19 on breast cancer care and treatment in North America: A scoping review

Kripalani, Simran; Kulshreshta, Srishti; Saracco, Benjamin; Meterissian, Sarkis

doi:10.1016/j.amjsurg.2022.07.015

Cited by 10 publications

(7 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Cancer patients, as a highly vulnerable population to better manage at a safe distance [ 19 ]. Telehealth visits were encouraged for non-emergent cases and follow-up appointments [ 20 ]. On these grounds, the American Society of Breast Surgeons, the National Accreditation Program for Breast Centers, the National Comprehensive Cancer Network, the Commission on Cancer, the American College of Radiology as well as the Italian Association of Medical Oncology provided preliminary guidance on the prioritization and treatment of BC during this particular period [ 10 , 21 ].…”

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients

Triki,

Zghal,

Ayed

et al. 2024

View full text Add to dashboard Cite

BACKGROUND: Breast cancer (BC) patients’ diagnosis and management was affected by a global reorganization after the Coronavirus disease 2019 (COVID-19). Our study aimed to assess the impact of the pandemic on the pathological stage of newly diagnosed patients with BC compared to pre-pandemic and to identify predictive factors of tumor advanced stage. METHODS: Pathological records of all consecutive newly operated BC patients between March 2020 and December 2021 were reviewed retrospectively. Clinical and pathological prognostic factors of BC were collected and compared between pre-pandemic and pandemic periods. Then, predictive factors of tumor advanced stage were identified. RESULTS: Of the 225 cases included in the analysis, 98.7% were females and 1.3% were males. The median time from first histological diagnosis to first surgical treatment was enlarged by 42 days with a significant difference between the two periods (p = 0.002). Newly diagnosed BC patients during the COVID-19 pandemic were operated at a more advanced stage (54.1% vs 36.2%, p = 0.007), had a greater lymphovascular invasion (p = 0.002), lymph node metastasis (p = 0.015) and are more commonly of IBC NST histological type (p = 0.005). Moreover, multivariate analyses showed that the pandemic period (AOR = 2.28; p = 0.016) and the lympho-vascular invasion (p < 0.001) were independently associated with advanced stage of tumors. CONCLUSION: Our findings proved an increase in alarming rates of advanced stage BC associated with the COVID-19 crisis. These findings support recommendations for a quick restoration of BC screening at full capacity, with adequate prioritization strategies to mitigate harm.

show abstract

Section: Discussionmentioning

confidence: 99%

Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients

Triki,

Zghal,

Ayed

et al. 2024

View full text Add to dashboard Cite

show abstract

“…A shift in hospital staff and resources caused an adaptive response in plastic surgery practices around the world, including delays in surgical treatment of breast cancer, an increased use of telehealth for follow-up, delays in the completion of final reconstruction, and methods to reduce hospital stays. [5][6][7][8][9][10][11] A comprehensive systematic review of these changes was conducted by Hemal and colleagues, who found a temporary reduction in autologous reconstruction, increased use of DTI over TE-based reconstruction, emphasis on expedited discharge postoperatively, and no significant increase in complications. 12 Indeed, a comparison of protocols before, during,…”

Section: F I G U R E 1 Flow Diagram Of Group Divisions Of Included Pa...mentioning

confidence: 99%

Safety and factors affecting same‐day discharge following mastectomy and immediate alloplastic reconstruction

Ghosh,

Shakir,

Kuchta

et al. 2023

Journal of Surgical Oncology

View full text Add to dashboard Cite

Background and ObjectivesPatients undergoing breast reconstruction following mastectomy are often admitted overnight. In 2020, our institution implemented a protocol change to discharge clinically stable patients immediately. In this study, we examine the safety of same‐day discharge following mastectomy and reconstruction.MethodsOur retrospective study included female adults undergoing mastectomy and immediate alloplastic reconstruction from August 2019 to January 2020, before implementation of the same‐day discharge protocol, and from March 2020 to September 2021, after the protocol implementation. Independent t‐test and chi‐square analysis was conducted to examine statistical differences.ResultsTwo hundred and eighty‐five patients were included. Forty‐two patients underwent reconstruction before the protocol change (Group 1) and 243 patients underwent reconstruction after the protocol change (Group 2). Group 2 had a greater percentage of prepectoral implant placement. There was no difference in demographics, complications, readmission, or reoperation. Within Group 2, 157 patients were discharged the same day (Group 2a) and 88 patients required overnight admission (Group 2b). Group 2b had higher body mass index, higher percentage of bilateral mastectomy, and larger mastectomy weights. Despite no differences in complications, Group 2b exhibited higher rates of requiring intravenous antibiotics and reoperation.ConclusionsPatients may be safely discharged the same day following mastectomy and alloplastic reconstruction without an increase in complications.

show abstract

“…Rayyan has also been used in diverse fields, but mostly in public health (e.g., Kripalani et al, 2022;Michelen et al, 2021;Torres-Castro et al, 2021). Rayyan has also been evaluated by different research teams (e.g., Harrison et al, 2020;Olofsson et al, 2017).…”

Section: Figurementioning

confidence: 99%

Study screening for meta-research: An overview of AI tools

Quan,

Hui

2023

Preprint

View full text Add to dashboard Cite

Second language acquisition (SLA) has seen a rapid increase in meta-research, such as systematic reviews and meta-analyses. This line of work has important implications, as it provides comprehensive overviews, establishes consensus, and identifies gaps in the literature on a given topic, both methodologically and substantively. However, the manual processes involved in meta-research can be resource intensive and, perhaps more importantly, prone to human errors. In this chapter, we provide an overview of artificial intelligence (AI) tools that have the potential to streamline meta-research processes, specifically in the context of literature screening. We discuss the strengths and weaknesses of these tools and share our experience using them. We conclude by recognizing that these AI tools are not a substitute for human expertise and judgements but offer exciting opportunities for researchers engaging in meta-research. Our overall goal is to help improve the efficiency, reproducibility, and transparency of meta-research in SLA.

show abstract

The effect of COVID-19 on breast cancer care and treatment in North America: A scoping review

Cited by 10 publications

References 24 publications

Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients

Impact of the COVID-19 pandemic on breast cancer pathological stage at diagnosis in Tunisian patients

Safety and factors affecting same‐day discharge following mastectomy and immediate alloplastic reconstruction

Study screening for meta-research: An overview of AI tools

Contact Info

Product

Resources

About